David E. Avigan
  • Print
Top Doctor

David E. Avigan


Treatments and procedures you offer:

  • Treatment for Multiple Myeloma, Acute Leukemia and Lymphoma
  • Clinical trials in cancer vaccines and CAR T cell therapy
  • Bone Marrow Transplantation

Business Summary

I am the Chief of the Hematologic Malignancy, Bone Marrow Transplantation and Cellular Therapy Program at Beth Israel Deaconess Medical Center. I lead a large research program in personalized immune based therapies for cancer including cancer vaccines and CAR T cells. We have developed a patient specific cancer vaccine. In clinical trials, vaccination was associated with disease regression and reduction in risk of relapse. We are now leading several national vaccine trials.

What’s your background, education and training?

  • M.D., Yale University School of Medicine, New Haven, CT
  • Postdoctoral Training Internships and Residency:
  • Resident and Chief Resident in Internal Medicine Columbia Presbyterian Medical Center, New York, NY
  • Fellow, Hematology/Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
  • Postdoctoral Research Associate, Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, NY

What advice would you give a patient looking to find a provider in your specialty?

I think it is critical to have a good understanding of the disease and the treatment options in an open and transparent way. Developing a close connection with your caregiver, and being able to explore these options together in a way that respects the individuality of each patient, and their situation is vital.

What inspired your passion for your profession?

We have the great privilege to care for patients at a difficult and uncertain time and offer support and help. Their courage inspires our whole team to work tirelessly to offer the highest level of care and seek better therapies.

What treatments are you most excited to offer?

We provide state of the art therapy including cutting edge research and personalized immune based therapies for patients facing blood cancers. I lead an integrated multidisciplinary team of clinicians and researchers that work together to emphatically deliver care with a focus on the unique qualities and dignity of each patient. We are proud to offer a large panel of clinical trials including personalized cancer vaccines and CAR T cells

Hours of operation:

8am-5pm, Monday-Friday

Insurances Accepted:

All major insurance, Medicare, and Medicaid

Keywords: Immunotherapy, hematological malignancies, CAR T, vaccine

Special expertise

Bone Marrow Transplant, Hematologic Malignancies


Top Doctor: 2019


Primary Hospital: Beth Israel Deaconess Medical Center-Boston
Secondary Hospital: Atrius Health - Quincy
Tertiary Hospital: Atrius Health - Quincy